The Fed’s Beige Book showcases 5 signs of economic pain flying under the radar
Federal Reserve officials spend a lot of time poring over reams of economic data, but sometimes it pays to take a more hands-on...
THNQ: AI Not As Hot A Sector As You May Think (NYSEARCA:THNQ)
Lastly, the fund's expense ratio is 0.68%, which is on the high side for a passively managed ETF. Conclusions While we...
Google Israel R&D head Yossi Matias moving to global role
Sources inform “Globes” that Prof. Yossi Matias, who for the past eighteen years has headed Google’s research and development center in Israel, is...
Women in couples report greater emergency savings than single ones
Being thirty, flirty, and thriving can be an uphill battle for single women these days. Weighed down by the persistent pay gap, unpartnered...
YS Biopharma Co., Ltd. (YS) Q3 2024 Earnings Call Transcript
YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Conference Call April 19, 2024 8:00 AM ET Company Participants Alyssa Li - Director, Investor...
Inhibikase Therapeutics progresses in Parkinson’s disease trials By Investing.com
BOSTON and ATLANTA – Inhibikase Therapeutics, Inc. (NASDAQ:IKT), a pharmaceutical company engaged in developing treatments for Parkinson’s disease and related disorders, has announced...